triazoles has been researched along with sulbactam in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haginaka, J; Nakagawa, T; Uno, T; Wakai, J; Yasuda, H | 1 |
Hall, TW; Ishida, N; Maiti, SN; Micetich, RG; Nakai, A; Ogawa, K; Spevak, P; Tanaka, M; Yamabe, S; Yamazaki, T | 1 |
Kim, KH; Park, KW; Yim, CB | 1 |
Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A | 1 |
Bajaksouzian, S; Barnes, MD; Bethel, CR; Bonomo, RA; Caillon, J; Jacobs, MR; Jacqueline, C; Papp-Wallace, KM; Potel, G; Reghal, A; Rutter, JD; Shapiro, S; Taracila, MA | 1 |
5 other study(ies) available for triazoles and sulbactam
Article | Year |
---|---|
High-performance liquid chromatographic assay of sulbactam using pre-column reaction with 1,2,4-triazole.
Topics: Animals; Cefoperazone; Chromatography, High Pressure Liquid; Kinetics; Male; Penicillanic Acid; Penicillins; Rats; Rats, Inbred Strains; Spectrophotometry, Ultraviolet; Sulbactam; Triazoles | 1985 |
Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Penicillanic Acid; Sulbactam; Tazobactam; Triazoles | 1987 |
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Citrobacter; Clavulanic Acid; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli Infections; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Pseudomonas Infections; Sulbactam; Triazoles | 1998 |
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole | 2014 |
Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor Combination.
Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Cefepime; Enterobacteriaceae; Piperacillin, Tazobactam Drug Combination; Spectrometry, Mass, Electrospray Ionization; Sulbactam; Triazoles | 2019 |